Jagasia, Madan
Iovance Biotherapeutics,
United States
2024 Rank: 63264
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1270 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63264 | 62510 |
| Total Cites | 1500 | 1713 |
| H-index | 17 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 463 | 495 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 522 | 560 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 958 | 1054 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.63 |
| Self-Citation Percentage |
12.43%
|
|
Jagasia, Madan
Vanderbilt-Ingram Cancer Center,
United States
2023 Rank: 74246
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1645 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74246 | 66897 |
| Total Cites | 1368 | 1601 |
| H-index | 16 | 18 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 414 | 462 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 483 | 531 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 933 | 1037 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.54 |
| Self-Citation Percentage |
14.55%
|
|
Jagasia, Madan
Iovance Biotherapeutics,
United States
2022 Rank: 62444
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1520 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62444 | 59788 |
| Total Cites | 1376 | 1705 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 385 | 424 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 455 | 502 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 969 | 1113 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.53 |
| Self-Citation Percentage |
19.30%
|
|
Jagasia, Madan
Vanderbilt University Medical Center,
United States
2021 Rank: 70186
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1585 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70186 | 67233 |
| Total Cites | 2025 | 2472 |
| H-index | 21 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 549 | 618 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 659 | 739 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1435 | 1633 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.51 |
| Self-Citation Percentage |
18.08%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.